Dengue vaccine: local decisions, global consequences

As new vaccines against diseases that are prevalent in low- and middle-income countries gradually become available, national health authorities are presented with new regulatory and policy challenges. The use of CYD-TDV – a chimeric tetravalent, live-attenuated dengue vaccine – was recently approved...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gatell, Hugo, Alpuche-Aranda, Celia M, Santos-Preciado, José I, Hernández-Ávila, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2016
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096346/
https://www.ncbi.nlm.nih.gov/pubmed/27821888
http://dx.doi.org/10.2471/BLT.15.168765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096346/
https://www.ncbi.nlm.nih.gov/pubmed/27821888
http://dx.doi.org/10.2471/BLT.15.168765

Ejemplares similares